Save Comparison | ![]() Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. | ![]() Innovation Pharmaceuticals Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications. | ![]() Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions. | ![]() Cellestia Biotech Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway. | |
Founding Date | Founding Date 2009 | Founding Date 2007 | Founding Date 2016 | Founding Date 2014 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Warren, US HQ | Locations Wakefield, US HQ Beverly, US | Locations Irvine, US HQ Basel, CH | Locations Basel, CH HQ Epalinges, CH | Locations Waltham, US HQ Lawrence, US Waltham, US |
Employees | Employees 1715% decrease | Employees 450% decrease | Employees 3950% increase | Employees 6 | Employees 438% increase |
Valuation ($) | Valuation ($) 75.1 m | Valuation ($) 90.1 m | Valuation ($) 513.6 m | Valuation ($) N/A | Valuation ($) 2.7 b |
Twitter followers | Twitter followers N/A | Twitter followers 182 | Twitter followers 109 | Twitter followers 143 | Twitter followers N/A |
Alexa Website Rank | Alexa Website Rank 264284 | Alexa Website Rank 226808 | Alexa Website Rank 450870 | Alexa Website Rank 374283 | Alexa Website Rank 288837 |
Employee Rating | Employee Rating 1 | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.6 |
Financial | |||||
Net income | Net income ($13.3m) (FY, 2019) | Net income ($6.6m) (FY, 2020) | Net income ($146.7m) (FY, 2020) | Net income N/A | Net income ($25.9m) (FY, 2016) |
Funding | |||||
Total funding raised | Total funding raised $ 80m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 48.6m | Total funding raised $ 142m |
Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.
View companyUrovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
View companyCellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
View companyDeciphera Pharmaceuticals is a clinical-stage biopharmaceutical company.
View company